Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on June 17, 2025
NexGold Receives Notice of Completion on Industrial Approval from the Government of Nova Scotia for the Goldboro Gold Project
GlobeNewswire
·
June 17, 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Government of Nova Scotia has deemed the Company’s application for an Industrial Approval of a Surface …
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
GlobeNewswire
·
June 17, 2025
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …
OROCO ANNOUNCES PRIVATE PLACEMENT
GlobeNewswire
·
June 17, 2025
VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 5,000,000 units of the Company (each, a “Unit”) …
Mobilicom to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025
GlobeNewswire
·
June 17, 2025
Mobilicom’s corporate presentation and investment thesis can be viewed here: LINK Palo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today …
ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire
·
June 17, 2025
CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with …
BCC Mining is a one-stop cloud mining platform that supports multiple cryptocurrencies and obtains potential profits
GlobeNewswire
·
June 17, 2025
Philadelphia, PA, June 17, 2025 (GLOBE NEWSWIRE) -- Crypto News: BCC Mining, the world's largest cloud mining platform, officially announced deep integration with multiple currencies: users can directly use multiple digital currencies for cloud mining. …
Short dramas, wide reach: Hengdian World Studios co-hosts cross-cultural film exchange
GlobeNewswire
·
June 17, 2025
HENGDIAN, China, June 17, 2025 (GLOBE NEWSWIRE) -- Hengdian Group subsidiary, Hengdian World Studios, and Shanghai-based Spanish film company, Dalynn Studio, co-hosted the International Short Drama …
Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma
GlobeNewswire
·
June 17, 2025
LYL314 demonstrated robust clinical responses, with an 88% overall response rate and a 72% complete response rate in patients treated in the third- or later-line setting (N = 25) 71% of patients with complete response remained in complete response at ≥ 6 …
VEON Appoints Vitaly Shmakov as Acting General Counsel
GlobeNewswire
·
June 17, 2025
Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), is pleased to announce that it has appointed Vitaly Shmakov as the Acting General Counsel, based in VEON’s headquarters in the Dubai International …
Omiyinka Doris Chooses to Step Aside from VEON General Counsel Position
GlobeNewswire
·
June 17, 2025
Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON; the “Company” or “VEON”), a global digital operator, today announces that Omiyinka Doris has chosen to step aside from her role as Group General Counsel of the Company effective July 1, 2025. Ms. Doris will …
Tariffs and U.S.-Canada relations are the top financial concern for seniors: new research from HOOPP and Abacus Data
GlobeNewswire
·
June 17, 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Geopolitical instability and the ongoing trade dispute with the United States have emerged as a major financial concern for Canadians and is having an impact on people’s retirement planning, according to the …
Telecom and TV providers urged to better inform customers about industry ombuds service
GlobeNewswire
·
June 17, 2025
OTTAWA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- A new report from the Commission for Complaints for Telecom-television Services (CCTS) reveals how well service providers have fulfilled their obligations to remain in good standing with the CCTS, Canada’s …
Prime Announces Completion of June Warrant Exercise
GlobeNewswire
·
June 17, 2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announces that 97% of its $1.10 warrants due June 12, 2025 have been exercised, which, including the …
Prospera Energy Announces Operations Update
GlobeNewswire
·
June 17, 2025
CALGARY, Alberta, June 17, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera”, “PEI” or the “Corporation”) Prospera Energy remains committed to providing stakeholders with transparent, timely, and data-driven updates on …
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
GlobeNewswire
·
June 17, 2025
- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel (mGnP), N=34; median OS and PFS not yet reached - - Striking tumor reductions with 39% overall response rate and 81% disease …
Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
GlobeNewswire
·
June 17, 2025
HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today congratulates its strategic partner …
Les fournisseurs de services de télécommunication et de télévision sont fortement encouragés à mieux informer leur clientèle au sujet du service de médiation offert pour ce secteur
GlobeNewswire
·
June 17, 2025
OTTAWA, Ontario, 17 juin 2025 (GLOBE NEWSWIRE) -- Un nouveau rapport de la Commission des plaintes relatives aux services de télécom-télévision (la CPRST) révèle dans quelle mesure les fournisseurs de services se sont acquittés de leurs obligations de …
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
GlobeNewswire
·
June 17, 2025
GROTON, Conn., June 17, 2025 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc., a clinical-stage biotechnology company today announced two major milestones that could change the way we protect brains from the damage caused by concussions and repeat head …
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
GlobeNewswire
·
June 17, 2025
DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold in the Business Change and Transformation Excellence category at the Industry Eagles Awards 2025, held on 5th June 2025 at The …
Les bons réflexes après une cyberattaque et pour protéger son SI
GlobeNewswire
·
June 17, 2025
Une cyberattaque peut bouleverser bien plus que les systèmes informatiques d’une entreprise. Elle affecte son image, ses clients, son fonctionnement quotidien. Pour une TPE ou une PME, ce genre d’incident peut mettre en péril toute l’activité si une …